All frameworks and cheat sheets

Reference table

Personalized pricing: what the evidence shows and what it does not

Table comparing what the FTC surveillance pricing findings and two price testing studies establish about personalized pricing, and what they leave open.
The tools for personal prices are widely sold. Measured use is low. Source: FTC surveillance pricing interim findings, 2025, and European Parliament, Personalised Pricing, 2022

A two-row summary of the evidence on personalized pricing. The FTC's 2025 interim findings show the infrastructure is sold to at least 250 client retailers. A European Commission mystery shopping study of 160 websites, and Vissers and colleagues' test of 25 airlines, found little detectable first-degree personalisation. Pricing and research teams can use it to separate capability from incidence before they plan a study.

Where this appears

What's in this reference table

What it establishesWhat it does not establish
FTC 6(b) interim findingsThe infrastructure exists, is commercially sold, and reaches at least 250 client retailersThat widespread individual price discrimination is occurring today
EC mystery shopping (160 sites) and Vissers (25 airlines)Detectable first-degree personalisation was rare and small in the settings testedThat it is not happening in untested settings, or now

Use this image

Free to use in your docs, decks and posts under CC BY 4.0, as long as you credit Koji with a link to this page. To embed it, paste this into your page:

html
<a href="https://www.koji.so/visuals/personalized-pricing-evidence-capability-vs-incidence"><img src="https://www.koji.so/visuals/personalized-pricing-evidence-capability-vs-incidence/personalized-pricing-evidence-capability-vs-incidence.png" alt="Table comparing what the FTC surveillance pricing findings and two price testing studies establish about personalized pricing, and what they leave open." width="1200" height="630" /></a>
<p>Source: <a href="https://www.koji.so/visuals/personalized-pricing-evidence-capability-vs-incidence">Personalized pricing: what the evidence shows and what it does not</a>, Koji</p>